- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03157986
Effects of Whole-Body Vibration Training Versus Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease
December 23, 2019 updated by: Klaus Kenn, Schön Klinik Berchtesgadener Land
Effects of a Three Week Whole Body Vibration Training Versus Conventional Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease
Aim of this study is to compare the effects of whole-body Vibration Training versus conventional Balance Training on Balance performance, gait quality and exercise capacity in patients with severe chronic obstructive pulmonary disease.
Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups.
On top of a standardized endurance and strength Training program (5 days per week) patients in both groups will perform an additional Balance Training (on 3 days per week).
Patients in both Groups will perform the same 4 different Balance exercises (2x1 Minute each): dynamic squats with closed eyes, heel raise, semi-Tandem stance and single leg stance but on a different surface.
The Vibration Training Group will perform the exercises on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz and the control Group will perform exercises on instable objects like Balance pads.
The degree of difficulty in both Groups will be individually adjusted and will be progressively increased, if possible.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Schoenau Am Koenigssee, Bavaria, Germany, 83471
- Schön Klinik Berchtesgadener Land
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COPD stage III or IV according to the global initiative for chronic obstructive lung disease
- impaired exercise capacity (6 Minute walk distance of less than 70% of the reference value from Troosters et al.)
Exclusion Criteria:
- current acute exacerbation of COPD
- carbon dioxide pressure of more than 45 mmHg at rest
- any contraindication for vibration Training (e.g. acute deep vein thrombosis)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Whole Body Vibration training
Balance Training on a Vibration platform
|
n=24 patients with severe chronic obstructive pulmonary disease.
Exercises will be performed on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz.
|
|
Active Comparator: Conventional Balance training
Balance Training on a Balance board
|
n=24 patients with COPD, Exercises will be performed on a Balance pad
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Balance Performance during semi Tandem stance
Time Frame: measurement on Day 1 and 21
|
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
|
measurement on Day 1 and 21
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle power during counter movement jump
Time Frame: measurement on Day 1 and 21
|
patients jump on a force platform as high as possible.
The Outcome is Watt per Kilogram Body weight
|
measurement on Day 1 and 21
|
|
Change in performance of the 5-Repetition-Raise-Test
Time Frame: measurement on Day 1 and 21
|
Patients try to perform 5 repetitions of standing up and sitting down from a chair with crossed arms on a force platform as quick as possible
|
measurement on Day 1 and 21
|
|
Change in performance of the 1-Minute-Chair-Rise-Test
Time Frame: measurement on Day 1 and 21
|
Patients try to perform as many repetitions as possible of standing up and sitting down from a chair with crossed arms on a force platform during 1 minute
|
measurement on Day 1 and 21
|
|
Change in Peak muscle strength of the knee Extension muscles
Time Frame: measurement on Day 1 and 21
|
isometric peak torque of the knee extensor muscles are measured in 90° knee angle
|
measurement on Day 1 and 21
|
|
Change in Peak muscle strength of the knee Flexion muscles
Time Frame: measurement on Day 1 and 21
|
isometric peak torque of the knee flexor muscles are measured in 90° knee angle
|
measurement on Day 1 and 21
|
|
Change in 6-minute Walk Distance
Time Frame: measurement on Day 1 and 21
|
patients are advised to walk as far as possible on a 30m track
|
measurement on Day 1 and 21
|
|
Change in 4m Gait Speed Test
Time Frame: measurement on Day 1 and 21
|
patients have to walk 4 meters at their usual Speed.
Outcome is the average Speed during the 4m walk.
|
measurement on Day 1 and 21
|
|
Change in step symmetry during 20m walking
Time Frame: measurement on Day 1 and 21
|
Patients walk 20m while wearing the Mc Roberts move test device (triaxial accelerometer) which performs a gait analysis
|
measurement on Day 1 and 21
|
|
Change in Hospital anxiety and Depression scale
Time Frame: measurement on Day 1 and 21
|
the Hospital anxiety and Depression scale is a questionnaire that evaluates signs of anxiety or depression
|
measurement on Day 1 and 21
|
|
Change in balance performance during Romberg stance
Time Frame: measurement on Day 1 and 21
|
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
|
measurement on Day 1 and 21
|
|
Change in Balance Performance during 1-leg stance
Time Frame: measurement on Day 1 and 21
|
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
|
measurement on Day 1 and 21
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Klaus Kenn, MD, Schoen Klinik Berchtesgadener Land
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2017
Primary Completion (Actual)
August 16, 2019
Study Completion (Actual)
August 16, 2019
Study Registration Dates
First Submitted
May 16, 2017
First Submitted That Met QC Criteria
May 16, 2017
First Posted (Actual)
May 17, 2017
Study Record Updates
Last Update Posted (Actual)
December 24, 2019
Last Update Submitted That Met QC Criteria
December 23, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WBVT Balance Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Balance Training on a vibration platform
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Asociacion Colaboracion Cochrane IberoamericanaCompleted
-
Trakya UniversityCompleted
-
Ebru Aloğlu ÇiftçiThe Scientific and Technological Research Council of TurkeyCompleted
-
Cairo UniversityRecruiting
-
University of Castilla-La ManchaCompleted
-
Hospital de MataróCompleted
-
The Hong Kong Polytechnic UniversityTung Wah HospitalUnknown
-
Maíra F PessoaCompleted
-
University of ValenciaINCLIVACompleted